In Victoria, Australian health officials are proposing to restrict permits that would allow patients with mental illnesses to access psychedelics in a therapeutic framework backed by research and clinical trials and “approved by a human research ethics committee.”  

At the moment, psychiatrists are allowed to apply for prescribing MDMA and psilocybin nationally through the Therapeutic Goods Administration (TGA) and the health department for patients who do not respond to other available treatments. 

So far, the TGA has approved 12 MDMA and 5 psilocybin applications, the first to be used with patients suffering PTSD and the latter for patients with treatment-resistant depression, depression related to a terminal condition or anxiety. 

Nonetheless, Victoria’s Department of Health stated that those permits were never approved by any state or territory and therefore the current proposal would be consistent …

Full story available on Benzinga.com